Company Showcase

Elevate your expectations. Demand more from your CDMO.


Recro Brochure


Recro Clinical Trial Services (CTS) Fact Sheet


White Paper: The Recro Approach to Proactive Improvement in Established QC

Posted By

Bill Hirschman

VP, Sales and Marketing

[email protected]

Cristin Grove

Senior Director, Business Development

[email protected]

Recro® provides oral solid dosage form development, regulatory support, clinical and commercial manufacturing, and packaging and logistics services to the global pharmaceutical market. Specializing in modified release oral solid dose and DEA controlled substances, Recro has the experts to deliver clients’ most complex pharmaceutical development, manufacturing, and packaging projects in its best-in-class, 120,000-square-foot manufacturing facility. For more information about Recro’s flexible CDMO solutions, visit

Sales Markets

Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)

Primary business activity


Contact information




View All Contact Info